Prevention of NSF is mainly focused on minimizing the use of high-risk GBCAs in patients with renal impairment. Alternative imaging methods that do not require gadolinium are preferred for these patients. If a GBCA is necessary, choosing a safer agent with a better safety profile and ensuring proper hydration and post-procedural dialysis can help reduce the risk.
